GOLDEN, Colo. — July 11, 2023 – PharmaJet®, a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals delivery today announced that Nanette Cocero, Ph.D., has been appointed to its Board of Directors. Dr. Cocero is a recognized leader in the global pharmaceutical industry with broad
View
GOLDEN, Colo. — June 28, 2023 – PharmaJet®, a company engineering precision delivery systems that overcome challenges of nucleic acid vaccine delivery, today announced that its Tropis® System is now the exclusive intradermal delivery system for two authorized novel Covid-19 vaccines:
View
GOLDEN, Colo. — June 6, 2023 – PharmaJet® a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals delivery today announced that Marie Mazur, PharmD, has been appointed Chair of the Board of Directors. She replaces Ron Lowy who had chaired the Board since 2011.
View
GOLDEN, Colo. — May 23, 2023 — PharmaJet®, a company engineering precision delivery systems that overcome the challenges of vaccine delivery, today announced their support for the World Health Organization’s (WHO) polio eradication campaigns in Pakistan starting in May 2023. PharmaJet is providing an additional 5 million syringes to the
View
GOLDEN, Colo. — May 2, 2023 – PharmaJet ® a company engineering Precision Delivery Systems™ that may overcome the challenges of vaccines and pharmaceuticals delivery today announced that Nathalie Landry, has been appointed Chief Scientific Officer.
View
GOLDEN, Colo. — April 18, 2023 —PharmaJet®, a company engineering Precision Delivery Systems™ (PDS) that overcome the challenges of vaccine delivery, today announced that it received a scope expansion and 3-year extension of its multi-year agreement with the Joint Science and Technology Office of the U.S. Defense Threat Reduction Agency
View
GOLDEN, Colo. — April 4, 2023 — Results of a comprehensive review of published scientific literature comparing data associated with various DNA vaccine delivery methods will be presented at the World Vaccine Congress 2023 on April 5, 2023 at 5:10 pm ET.
View
GOLDEN, Colo. — April 3, 2023 – Following completion of Phase II/III study, PharmaJet partner Gennova Biopharmaceuticals Limited has submitted data for its mRNA-based Omicron specific Covid-19 booster shot for Emergency Use Authorization (EUA) to the office of the drug controller General of India (DCGI). The submission corresponds with an
View
GOLDEN, Colo. — March 21, 2023 — PharmaJet®, a company engineering precision delivery systems that may overcome the challenges of nucleic acid vaccine delivery, today announced that its partner, Scancell, a developer of novel immunotherapies for the treatment of cancer and infectious diseases, reported positive results from their Phase 1
View
Load more